Cullinan Therapeutics, Inc. (CGEM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 611.17M |
| Enterprise Value | 525.52M |
| P/E Ratio | -4.61 |
| PEG Ratio | 0.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.55 |
| Return On Equity | -0.51 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -219.57M |
| Net Income | -219.88M |
| Diluted EPS | -3.72 |
| Total Cash | 351.89M |
| Total Cash/Share | 5.94 |
| Total Debt | 2.38M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 10.28 |
| Book Value Per Share | 6.19 |
| 52-Week Change | 128.23 |
| 52-Week High | 17.4 |
| 52-Week Low | 5.68 |
| Moving Average 50 Days | 14.47 |
| Moving Average 200 Days | 11.47 |
| Average Volume | 1.03M |
| Shares Outstanding | 61.46M |
| % Held by Institutions | 110.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |